FDA Should Release Existing Supply Of Primatene Mist OTC Asthma Inhaler, Rep. Says

Lawmakers seek to restore the availability of Primatene Mist while the absence of an alternative OTC asthma remedy persists.

FDA should release the existing supply of OTC asthma inhaler Primatene Mist so consumers have a nonprescription emergency treatment available until one can be developed that meets rules governing ozone-depleting chemicals, Rep. Mike Ross says.

The Arkansas Republican said 1 million inhalers are in a warehouse in California. “Americans are without an OTC emergency inhaler...

More from United States

More from North America